As of April 15, 2025, Recordati (REC.MI) has a market cap of $11.26 billion USD. According to our data, Recordati is ranked No.1466 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 15, 2025 | $11.26 B |
-4.68%
|
Dec 30, 2024 | $11.81 B |
6.16%
|
Dec 29, 2023 | $11.13 B |
29.35%
|
Dec 30, 2022 | $8.60 B |
-29.50%
|
Dec 30, 2021 | $12.20 B |
27.33%
|
Dec 30, 2020 | $9.58 B |
23.40%
|
Dec 30, 2019 | $7.77 B |
27.31%
|
Dec 28, 2018 | $6.10 B |
-15.77%
|
Dec 29, 2017 | $7.24 B |
40.69%
|
Dec 30, 2016 | $5.15 B |
14.83%
|
Dec 31, 2015 | $4.48 B |
92.51%
|
Dec 30, 2014 | $2.33 B |
26.30%
|
Dec 30, 2013 | $1.84 B |
56.84%
|
Dec 28, 2012 | $1.18 B |
30.25%
|
Dec 30, 2011 | $0.90 B |
-14.63%
|
Dec 30, 2010 | $1.06 B |
42.22%
|
Dec 30, 2009 | $0.74 B |
42.51%
|
Dec 30, 2008 | $0.52 B |
-33.78%
|
Dec 28, 2007 | $0.79 B |
8.35%
|
Dec 29, 2006 | $0.73 B |
2.15%
|
Dec 30, 2005 | $0.71 B |
36.31%
|
Dec 31, 2004 | $0.52 B |
17.84%
|
Dec 31, 2003 | $0.44 B |
2.62%
|
Dec 31, 2002 | $0.43 B |
-30.25%
|
Dec 31, 2001 | $0.62 B |
-109.91%
|
Dec 29, 2000 | $-6.24 B |
-574.22%
|
Dec 31, 1999 | $1.32 B |
-101.44%
|
Dec 31, 1998 | $-91.53 B |
-101.81%
|
Dec 31, 1997 | $5.051 T |
-101.37%
|
Dec 31, 1996 | $-367.632 T |
-101.88%
|
Dec 29, 1995 | $19,546.522 T |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Pfizer
PFE
|
$127.27 B |
-0.003 M
|
![]() USA
|
![]() Merck
MRK
|
$197.26 B |
0.003 M
|
![]() USA
|
![]() Rogers Corporation
ROG
|
$1.00 B |
0.000 M
|
![]() USA
|
![]() Santander
SAN
|
$101.44 B |
0.553 B
|
![]() Spain
|
![]() GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
![]() UK
|
![]() AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
![]() USA
|
![]() Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
![]() USA
|
![]() Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
![]() USA
|
![]() AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
![]() UK
|
Market Cap | = | REC.MI Stock Price | * | REC.MI Shares Outstanding |
= | $54.66 | * | 0.21 B | |
= | $11.26 B |